(Q40597029)

English

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens.

scientific article published on September 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

David W Scheifele

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

S A Halperin

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A C Ferguson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

0 references

publication date

1 September 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

4720-4726

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Delayed hypersensitivity to tetanus toxoid in man: in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between cutaneous delayed hypersensitivity and cell-mediated immunity in vitro responses assessed by diphtheria and tetanus toxoids

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Skin immunization made possible by cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900230-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(01)00230-4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11535322%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40597029&oldid=1502016293"